FLPIM
AZN icon

F.L. Putnam Investment Management’s AstraZeneca AZN Stock Holding History

F.L. Putnam Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1M Sell
142,906
-5,513
-4% -$1.04M 0.32% 58
2026
Q1 		$29.3M Sell
148,419
-19,360
-12% -$3.73M 0.44% 42
2025
Q4 		$30.8M Buy
167,779
+6,028
+4% +$1.06M 0.45% 44
2025
Q3 		$24.8M Buy
161,751
+2,969
+2% +$449K 0.37% 55
2025
Q2 		$22.2M Buy
158,782
+5,494
+4% +$770K 0.38% 54
2025
Q1 		$22.5M Buy
153,288
+6,501
+4% +$941K 0.42% 54
2024
Q4 		$19.2M Buy
146,787
+28,129
+24% +$3.94M 0.35% 60
2024
Q3 		$18.5M Buy
118,658
+1,228
+1% +$198K 0.33% 64
2024
Q2 		$18.3M Sell
117,430
-21,436
-15% -$3.23M 0.34% 64
2024
Q1 		$18.8M Buy
138,866
+2,819
+2% +$373K 0.4% 56
2023
Q4 		$18.3M Buy
136,047
+15,314
+13% +$1.99M 0.43% 53
2023
Q3 		$16.4M Buy
120,733
+1,556
+1% +$213K 0.45% 51
2023
Q2 		$17.1M Buy
119,177
+2,316
+2% +$341K 0.46% 46
2023
Q1 		$16.2M Buy
116,861
+4,568
+4% +$615K 0.53% 45
2022
Q4 		$15.2M Buy
112,293
+12,306
+12% +$1.54M 0.55% 47
2022
Q3 		$11M Buy
99,987
+2,448
+3% +$311K 0.43% 55
2022
Q2 		$12.9M Buy
97,539
+11,795
+14% +$1.55M 0.47% 52
2022
Q1 		$11.4M Buy
85,744
+2,256
+3% +$271K 0.36% 63
2021
Q4 		$9.73M Buy
83,488
+3,659
+5% +$431K 0.3% 69
2021
Q3 		$9.59M Buy
79,829
+29,888
+60% +$3.48M 0.33% 70
2021
Q2 		$5.98M Buy
49,941
+6,693
+15% +$734K 0.21% 96
2021
Q1 		$4.3M Buy
43,248
+4,193
+11% +$422K 0.19% 104
2020
Q4 		$3.9M Buy
+39,055
New +$4.14M 0.18% 100

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

F.L. Putnam Investment Management's AZN Position: Q2 2026 in Review

F.L. Putnam Investment Management reduced its AstraZeneca (AZN) stake by 3.7% in Q2 2026, selling an estimated $1.04M and leaving 142,906 shares worth $27.1M. The position accounts for 0.32% of the portfolio, ranked #58.

F.L. Putnam Investment Management first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $30.8M in Q4 2025. 977 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • F.L. Putnam Investment Management held 142,906 shares of AstraZeneca worth $27.1M as of Q2 2026.
  • F.L. Putnam Investment Management sold 5,513 AstraZeneca shares in Q2 2026, an estimated $1.04M.
  • AstraZeneca made up 0.32% of F.L. Putnam Investment Management's portfolio in Q2 2026, its #58 holding.
  • F.L. Putnam Investment Management first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
  • F.L. Putnam Investment Management's AstraZeneca position peaked at $30.8M in Q4 2025.
  • 977 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on F.L. Putnam Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.